Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1386 in impacted third molar extraction pain
NCT00672646Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2008
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of AZD-1386 in postoperative pain (3 arms), sponsored by AstraZeneca. Primary endpoint: Sum of Pain Intensity Difference in Percent. Started Apr 2008; status: completed.
02
Drugs
AZD-1386
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00672646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00672646.